Sepio Capital, LP Biogen Inc. Transaction History

Sepio Capital, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	BUY	$187.54 - $223.02 $313,566 - $372,889	1,672 Added 18.34%	10,788 $2.2 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $72,469 - $91,308	374 Added 4.28%	9,116 $1.92 Million
Q4 2021 Jan 25, 2022	BUY	$223.92 - $287.77 $1.96 Million - $2.52 Million	8,742 New	8,742 $2.1 Million
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $882,413 - $1.41 Million	-3,407 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $827,730 - $969,734	3,407 New	3,407 $953,000
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $201,766 - $303,708	-854 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $245,177 - $283,087	-926 Reduced 52.02%	854 $242,000
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $32,591 - $43,161	-126 Reduced 6.61%	1,780 $476,000
Q1 2020 Apr 29, 2020	BUY	$268.85 - $341.04 $144,641 - $183,479	538 Added 39.33%	1,906 $603,000
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $301,042 - $415,967	1,368 New	1,368 $406,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Sepio Capital, LP with notifications on news.